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Summary 
Human severe combined immunodeficiency (SCID) patients were analyzed by a polymerase chain 
reaction assay for their recombination capability at the D.Qsa-J. region of the immunoglobulin 
heavy chain locus. Five patients with B cells (B + SCID) exhibited a recombination pattern also 
observed in healthy persons. In contrast,  six patients lacking B cells (]3- SCID) showed a grossly 
altered  rearrangement  pattern  characterized  by  the  (partial)  absence  of  regular  D.Qs~-J, 
recombinations and the presence of abnormal rearrangements. These events were caused by deletions 
surpassing the boundaries  of immunoglobulin coding elements and thus resemble the pattern 
of deletional  recombinations previously described in SCID mice. 
H 
uman SCID is a rare, heterogeneous congenital disorder 
of the lymphatic system (1,  2).  Affected infants  are 
characterized by severe and persistent  infections due to the 
impaired function of B and T lymphocytes.  Without bone 
marrow transplantation  the patients  usually die before the 
age of two years (1). 
In approximately  15-20% of patients,  SCID is associated 
with  a  deficiency  of  the  enzyme  adenosine  deaminase 
(ADA)L Additional immunodeficiencies are characterized by 
abnormalities of the enzymes purine nucleoside phosphory- 
lase (PNP) and ecto-5'-nucleotidase  (3). 
Rare cases of SCID can also result from the inappropriate 
expression of restriction elements of the HLA loci (4-6), defec- 
tive II.-2 production (7, 8), the failure of T cells to respond 
to II:1 (9), impairments in the T cell receptor/CD3 complex 
(10, 11), abnormalities of the cytoskeleton and from distur- 
bances of signal transduction pathways within T cells (12). 
Frequently, human SCID is inherited as a X-linked, recessive 
trait (McKusick no. 30040 SCID X1), characterized by the 
absence of mature T cells and normal or elevated numbers 
of B cells (13). The SCID subentities  mentioned above all 
bear detectable numbers of B cells in their peripheral blood. 
However, occasionally patients have been reported in which 
B and pre-B cells are completely absent  (B-  SCID),  sug- 
1 Abbreviations  used in this paper: ADA, adenosin deaminase; DTH, delayed 
type of hypersensitivity; PNP, purine nucleotide phosphorylase; RSS, 
recombination signal sequence; TdT, terminal  desoxyribonucleotidyl 
transferase. 
gesting a distinct type of SCID with a profound defect of 
the lymphocyte development  (14). 
One of the crucial steps for the development of functional 
lymphocytes is the correct joining of distinct subgenic ele- 
ments (V(D)J recombination) to generate coding sequences 
for Ig or TCR variable regions (15, 16). The joining process 
is mediated by signal sequences (RSS: recombination signal 
sequences) flanking each coding element. The juxtaposition 
of two coding elements is usually associated with modifica- 
tions at the junctional region, due to the loss of a few bases 
at  the coding ends  and de novo  insertion of nucleotides 
(N-nucleotides), most likely mediated by the enzyme terminal 
desoxynucleotidyl  transferase (TdT)  (17). The  process  of 
N-region insertion is developmentally regulated in B and T 
cells, with the number of N-nudeotides included in the junc- 
tional region increasing with time after birth (18-20). Alter- 
natively, extra bases may represent inverted repeats (pallin- 
dromes) at the termini from the adjoining coding segments 
(P-nucleotides)  (18, 19). 
The rearrangement of the V, (D) and J elements is tightly 
controlled, occurs in a preferential order (e.g., Dj.  before 
V.DaJ. recombinations,  subsequently  Vd~ recombination) 
and is lineage specific (TCR loci are usually not completely 
rearranged  in B cells and vice versa) (21). 
The recombination process is thought to be mediated by 
an enzymatic machinery (V(D)J  "recombinase")  which is 
common to B and T  cells (22). 
A mouse model in which the correct assembly of the sub- 
genic V, (D), J elements is defective, has been described (23). 
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early lymphoid differentiation. Thus young mice, homozy- 
gous for SCID, lack functional T  and B lymphocytes and 
phenotypically resemble B- SCID patients. However, trans- 
formed cell lines which have a phenotype characteristic of 
immature lymphocytes  can be obtained from SCID mice. The 
crucial finding made in those transformed lymphocytes was 
that rearrangements (on the IgH and TCRB loci) often deleted 
the entire J cluster and extended into the flanking regions 
(25-29). Recent analysis of the TCK3~ (30) and IgK loci (31) 
confirm these findings. These studies support that the recom- 
binase system in SCID mice is capable of cleaving the DNA 
at the correct position (between KSS and coding elements) 
and joining the signal elements, but fails to mediate the for- 
mation of normal coding joints (31, 32).  It remains to be 
established  whether correct rearrangement events observed 
in older SCID mice are due to spontaneous revertants or rather 
reflect a low-frequence "leakiness" of the mutated recombimse 
(33) and whether the routine SCID mutation is caused by 
a more general defect in DNA repair (34). 
In this report, we have examined the rearrangement capa- 
bility of B cell negative (B-) and B cell positive (B +) human 
SCID patients. Since in contrast to the murine SCID model, 
the establishment of transformed cell  lines  poses  a major 
problem, we used a sensitive PCR assay to characterize en- 
dogenous D.Qs2 to J, rearrangements. We conclude from 
these experiments that the B- SCID patients are character- 
ized by an impaired rearrangement process at the J. region 
analogous to the defect in SCID mice. 
Materials and Methods 
Patients.  SCID was diagnosed according to the criteria defined 
by the World Health Organization classification  (2). These included 
radiological  absence of  a thymus shadow, severely  reduced or unde- 
tectable Ig levels, severely  impaired cellular immune functions, and 
negative delayed  type of  hypersensitivity  (DTH) reactions following 
immunization. ADA and PNP activities were normal. The clinical 
and immunological characterization of the patients is outlined in 
Table 1. Antibodies and immunofluorescence techniques for the 
phenotypic analyses have been described elsewhere (35). On the 
basis of the expression of the CD20 marker on PBMC cells the 
patients were subdivided  into a B cell positive group (five  patients) 
and a B cell negative group (six patients). All patients except one 
(patient 7, T.C.) exhibited various amounts of CD3 positive cells, 
i.e., T lymphocytes. In vitro cultures of PBMC on feeder cells and 
with rib2 showed the presence  of  CD3 positive  cells  in five  of  eight 
patients. In B-  SCID patients these cells were characterized by 
serological HLA typing as exclusively  of maternal origin (35). In- 
formed consent was obtained from the parents for all diagnostic 
and therapeutic procedures. Samples of healthy bone marrow or 
blood donors served as control. 
Cell Isolation.  Mononuclear cell fractions from bone marrow 
aspirates and peripheral blood were obtained by density gradient 
centrifugation over Ficoll-Hypaque (1.077 g/ml; Nycomed, Oslo, 
Norway). 
Southern Blot Analysis.  High mol wt DNA was prepared from 
the isolated cells according to a previously  published protocol (36). 
To investigate IgH gene configuration, genomic DNA (10-15/~g) 
was digested with Bgl II or Hind III (Pharmacia, Freiburg, Ger- 
many), electrophoresed through a 0.8% (w/v) agarose gel, trans- 
ferred to nylon membranes (Schleicher and Schuell, Dassel, Get- 
Table  1.  Clinical and Immunological Characterization of Severe Combined Immunodeficiency (SCID) Patients 
Phenotype* 
Sex  Age*  CD20  CD3  TCRce/B  CD15  CD16  Maternal T  cells  s 
B  § SCID 
patients 
B-  SCID 
patients 
1  D.B.  m  8mo 
2  D.D.  m  ld 
3  K.K.  m  17 mo 
4  F.P.  m  ld 
5  M.Z.  m  4mo 
6  V.M.  f  ld 
7  T.C.  m  2too 
8  P.P.  f  lmo 
9  J.B.  m  lmo 
10  J.J.  m  3 mo 
11  S.K.  m  6 mo 
18  14  14  25  39  + 
65  7  ND  ND  7  ND 
20  0.2  ND  31  1  ND 
27  5  ND  54  2  - 
26  1  ND  ND  0  - 
0  45  38  36  12  + 
0  0  0  34  14  - 
0  67  73  5  26  + 
0  44  48  32  17  ND 
<1  70  64  8  19  + 
0  3  2  3  67  + 
* Percentage of PBMC which were stained by indirect immunofluorescence. 
* The age of the patients at diagnosis. 
s Maternal T calls are present (+) or absent ( - ) in an in vitro culture system of PBMC (35). 
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were radiolabeled  by hexanudeotide priming (37). Washing of the 
membranes included a high stringency step at 63~  in 0.1  x 
SSC/0.1% SDS. 
Pol2/merase Chain Reaction.  PCR was essentially performed as 
suggested by Saiki et al. (38). A 100 pl reaction mixture contained 
0.5-1 pg of  genomic DNA (when indicated, digested with BamH 
I, Bgl II, or EcoN I), 50 pmol of each 5' and 3  ~  oligonudeotide 
primer, 200 #mol/I dATP, dCTP, dGTP, and dTTP, 10 mmol/I 
Tris-HC1 pH  8.3, 50  mmol/I KCI,  2.5  mmol/I MgCh  and 
0.001% (w/v) gehtine. The reaction mixture was exposed for 10 
min to 302 nm UV light on a Vilber Lourmall transiUuminator 
(Bachhofer, Reutlingen, Germany) before the addition of  genomic 
DNA. Oligonudeotide primers are listed below (see: Oligunude- 
otides) and their position within the J. region is depicted in Fig. 
1. After an initial denaturing step of 10 min at 95~  1.5 U Am- 
plitaq polymerase (Cetus Corp., Norwalk, CT) and 1/A of gp32 
(Pharmacia) (39) were added and 30 amplification cycles  were run 
in an automatic PCR processor (Bio-Med, Theres, Germany). Fol- 
lowing the initial denaturation, the melting, annealing and exten- 
sion steps were performed at 94~  for 2 min, 56~  for 90 s and 
72~  for 5 min, respectively. The final cycle was followed by an 
additional extension for 10 rain at 72~ 
10% of the amplification  products were separated on an agarose 
gel (0.8% or 1.2%) and studied by Southern blot analysis. 
Isolation, Cloning and Sequencing of Amplified DNA.  20-50% 
of the amplified  DNA was cleaved  with appropriate restriction en- 
zymes (Pharmacia) to allow for directional cloning, ligated into 
pBSKSM13+ (Stratagene, Heidelberg, Germany) or pT7T3U18 
(Pharmacia) vectors and transformed into RRllacZAM15 Esche- 
richia coil 
White colonies were picked and rescreened  by colony hybridiza- 
tion with oligunudeotides 3, 4, or 5 (see below). 
Plasmid DNA for sequence analysis  was isohted from each  recom- 
binant clone via alkaline lysis. Sequencing followed the dideoxy 
chain termination method described  by Sanger (40) using T7 DNA 
polymerase  according to the instructions of the manufacturers (US 
Biochemical, Cleveland, Ohio)  (Pharmacia). 
Evaluation of the sequences was done with version 6.2 of the 
University of Wisconsin Genetics Computer  Group (GCG) se- 
quence analysis package (41). 
Probes.  For hybridization studies we used two probes, each 
covering part of the Ig-J. locus. Probe a (Fig. 1) is a 2.5 kb frag- 
ment starting 5' of  J,3 and ending at the Bgl II site of the Cp en- 
hancer (42). A second probe (probe b, Fig. 1) was generated by 
PCR amplification of undigested genomic DNA using oligonu- 
cleotides 2 and 6. A plasmid containing the germline configura- 
tion of the D.Qs2- J. region was obtained after cloning and colony 
hybridization. A BamH I/Nco I digest yielded a 1.1 kb fragment 
which spans the region from oligonucleotide  2 to base 1103. Nucleo- 
tide numbering follows a published sequence of the J, locus (43). 
Oligonucleotides.  Synthetic oligonudeotides were prepared ac- 
cording to published sequences (43). The oligonucleotides were 
used for hybridizations (H), PCR (P), or sequence analyses (S). 
Oligonudeotide 1: (P), 5' ACC CAG CAC TGG TGG ACA 
C; Oligonudeotide 2: (P), an additional BamHI site (underlined) 
for cloning was synthesized. 5' GAC GGA TCC AGT GC~ ACG 
ACG GTG AAC; Oligonucleotide 3; (H, S), 5' CCT ACC AGC 
CGC AGG GT; Oligonucleotide 4: (H), 5' GCG CTA CAA AAA 
CCA TGC TCC; Oligonucleotide 5: (H, S) 5' CGT GGT CCC 
TTG CCC CCA GAC; Oligonudeotide 6: (P), an additional Sal 
I site is underlined. 5' GCC GTC GAC GGC AGT AGC AGA 
AAA CAA AGG. 
In addition, we used T3 and T7 oligonucleotides (Pharmacia) 
for sequence analyses. 
Results 
D,  QsrJ,~ Polymerase Chain Reaction Assay.  We decided to 
make use of the enormous sensitivity of the PCR technique 
for the detection of D.Qsz-J. associated rearrangements. The 
assay was designed such that one primer pair could amplify 
the germline band and all six possible D.Qs2-J. rearrange- 
ments simultaneously (the design of the test system and ex- 
pected rearrangements are outlined in Fig.  1). In addition, 
by placing the 5' PCR oligonucleotide(s) about 500-600 bp 
upstream of DsQs~, we could also  detect possible  deletion 
events.  The  fragments  representing  D.Qs2-J. associated 
recombination events were visualized by Southern blot analysis. 
We initially amplified the bone marrow DNA of healthy 
donors. Fig. 2 A  is the result of one representative experi- 
ment. Amplification products of expected size are visible and 
represent a "ladder" of D.Qs2-J. rearrangements. Reproduc- 
ible amplifications especially of the larger products were only 
achieved after inclusion of gp 32 in our PCR approach (39). 
DH  JH 
Q52 
I  2  3  4  5  6 
B  E 
OLIGOMERS 
PROBB b 
PROBE a 
EXPECTED  RECOMBINATION 
-" D-[]-qS--C--[:5~ 
PRODUCTS 
Kb 
3.0 
=3-C--U-C--D~3  2.9 
2.7 
=3--q3-q3-~  2.1 
1.7 
1.2 
:ID--  0.6 
Figure 1.  Schematic  drawing  of the strategy  used for the amplification 
of possible D.Qs2-JH recombination  events. A sketch  of the D.Qs2-J. locus 
is shown; pseudo  J. dements are omitted  for the sake of clarity. The po- 
sition of the oligonucleotides  used is indicated,  as well as the localization 
of probe a and probe b. Abbreviations  of restriction enzymes  are: B, Bgl 
II; E, EcoN I. Rearrangement  patterns and expected  sizes of the recombi- 
nation products at the D~s2-J. locus are presented. The sizes of the PCR 
products were  calculated  for oligonucleotides  2 and 6. When oligonucleo- 
tide 1 is used  as 5' primer, the respective  sizes  will  increase  by about 100 bp. 
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representing D.Q52-J. rearrangements. The DNA was separated on a 0.8% 
agarose gd and hybridized to probe a (Fig. 1 A). As size marker, Hind 
Ill digested )~ DNA was included.  (,4) Genomic DNA of normal bone 
marrow was either used without restriction enzyme digestion (lane 1 and 
4) or with prior cleavage by EcoN I (lane 2 and 5) or BamH I (lane 3 
and 6); BamH I does not cut within the DHQ52-J. region. The DNA was 
amplified with oligonudeotides 1 and 6 (lane 1-3) or with primers 2 and 
6 (lane 4-6). (B) Genomic  DNA digested with EcoN I was amplified with 
oligonucleotides 2 and 6. Lane I, water; lane 2, salmon sperm DNA; lane 
3. mouse liver DNA; lane 4, EG66 DNA (neuroblastoma cell line); lane 
5, HT 29 DNA (colon adenocarcinoma cell line); lane 6, small cell lung 
Undigested DNA or DNA restricted with either EcoN I 
(cuts between DHQs2 and J.1) or BamH I (no restriction site 
within the amplified region) was tested in the PCR reaction. 
Amplification of the EcoN I digested DNA reduced the strong 
signal obtained by the germline fragment in amplifications 
of undigested or BamH  I  digested  DNA and allowed  to 
differentiate the DHQs2-J.2 rearrangement from the germline 
signal. The D.Qs2-J.1 rearrangement was probably disclosed 
by the germline signal in our gel system or, since it occurs 
very rarely (44), it was too weak to be visualized (Fig. 2 A). 
Even when the DNA was cut with EcoN I we amplified a 
germline band. This reflects the sensitivity of the PCR reac- 
tion to detect rare sequences. The identity of the fragments 
as  D.Q52-J. rearrangements was  further  supported by  the 
smaller size of the bands (Fig. 2 A, lane 4-6), when oligonu- 
cleotide 2 (Fig.  1) was used as upstream primer instead of 
oligonucleotide 1.  In addition, hybridization with specific 
oligonucleotides representing J,2-J.6 sequences confirmed the 
conclusion  that  respective bands  represent  rearrangement 
events. Analysis  of the amplification products which have been 
digested with Nco I (cuts between J.2 and J.3), ApaL I (cuts 
between J.3  and J.4) or Hinc II (cuts between J.4  and J.s) 
supported this view (data not shown). 
The specificity of the assay was proven by the absence of 
amplification products when nonhuman DNA (salmon sperm 
or mouse liver DNA) (Fig.  2 B) was used.  In addition, a 
panel of human cell lines (Fig. 2 B) was analyzed to test the 
fidelity of the reaction. In fact, only the germline signals were 
observed upon amplification of DNA obtained from all six 
cell lines tested. 
Sequence Analysis of DHQsrJ,~  Associated Rearrangements of 
Healthy Persons.  Amplification  products  of bone marrow 
DNA (cut with EcoN I) of two healthy donors were cloned. 
After selection by lac.Z c~ complementation, rearrangement 
events were scored  by hybridization to oligonucleotide 3 and/or 
5 (Fig. 1). Clones hybridizing to oligonudeotide 4 were ex- 
cluded from sequence analyses since they represented most 
likely germline amplifications. We sequenced 29 clones (done 
1-29, Fig. 3 A) which hybridized to oligonucleotide 3 and 
5, and one clone (clone 30, Fig. 3 A) which hybridized only 
to oligonudeotide 5, representing two D~Qsz-J.4, five  D.Qs2- 
Js5 and 23 DHq52-Ja6  rearrangements.  The distribution of J. 
rearrangements probably reflects a double bias in amplification 
and cloning efficiency where fragments  of smaller size are 
favoured. The J.4 and Ja6 elements that were sequenced were 
in complete accordance with those published by Yamada et 
al. (44) and showed some nucleotide substitution compared 
with another report  (43).  The Jas sequences derived from 
our analysis rather represent a composition ofJ.s nucleotide 
sequences recently published (43, 44). Six of 30 clones (20%) 
lacked evidence for N nucleotides insertion (done 1, 3, 8-11). 
The GC content of N regions was 65.4%. Both values cor- 
respond to published data (45). Twenty of 30 clones (66.7%) 
carcinoma  cell  line DNA; lane 7, lung  fibroblast  DNA; lane 8, skin fibmblast 
DNA; lane 9, skin fibroblast DNA of a FILA class II deficient SCID pa- 
tient; lane 10, bone marrow DNA of a healthy donor. 
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DBO$2-J.~  rearrangements 
DSQ52  N 
*CTAACTGCCGA, 
1  CTAACTGUGG 
2  CTAACTGGGG  CA 
JR4 
~ACTACTTTCACTACTCGGGCCAAGGAACCCTG... 
...................  C ......... .. 
CCAGGGAACCCTG. 
GCGCCAGGGAACCCTG... 
DuO52-JH5  rearrangements 
DHO52  N 
.CTAACTGGGGA~ 
3  CTAACTGGGGA 
4  CTAACTGGGGA  C 
5  CTAACTGGGC  CA 
6  CTAACTGGGC  CGGCA 
7  CT  Ct~ATTr 
Js5 
"ACAACTGCTTCCACTCCTGCGGCCAAGGAACCCTG... 
-A ............  C ..........  G .......  ... 
ACAACTGCTTCCACCCCTCGGGCCAGGGAACCCTC,.. 
CAACTGGTTCCACCCCTGGGGCCAGGGAACCCTC... 
TGGGGCCAGGGAACCCTG... 
TGCTTCGACCCCTGGGGCCACGGAACCCTG... 
CGACCCCTGGGGCCAGGGAACCCTC.. 
DHO52-Jss  rearrangements 
Dao52  N 
-CTAACTGGGGA~ 
8  CTAACTGGGGA 
9  CTAACTGGGGA 
1O  CTAACTGGG 
ii  CTAACTGGG 
12  CT  ~A 
13  CTAACTGGG 
14  CTAACTGGGG~  ~TA 
15  CTAACTG  TGAC 
16  CTAACTGGC  AATT 
17  CTAACT  TCTC 
18  CTAACTGGG~A  T  CCTCCG 
19  CTAACTGGG~A  T~CTGGG 
20  CTAACTGGCGA  CTCTTG 
21  CTAACTGGGG  GGGGGG 
22  C  CTAAGG 
23  CTAACTGGGG  GGGGGGG 
24  CTAACTGGGG  CGGACCGC 
25  CTAACTGGGG  GGGAGCGG 
26  CTAAC  CCCCCAGG 
27  CTAACTGGGGA  TCTTTGTTAGG 
28 
29 
30 
Js6 
"ATTACTACTACTACTACGGTATGG~CGTCTGGGC~C,. 
...............................  C-.. 
............................  CA.. 
TTACTACTACTACTACGGTATGGACGTCTGGGGCC~. 
CTACTACTACTACGGTATGGACGTCTGGGGCC., 
TACTACTACTACGGTATGCACGTCTGGGGCC.. 
TACGGTATGCACGTCTGGGGCC.. 
CGGTATGGACGTCTGGGGCC.. 
ACTACTACTACGGTATCGACGTCTGGGGCC.. 
TACTACTACGGTATGGACGTCTGGGGCC.. 
CTACTACTACTACGGTATGGACGTCTGGGGCC., 
CTACTACTACGGTATGGACGTCTGGGGCC.. 
TACTACTACTAC  ATGGACGTCTGGGGCA., 
TACTACTACGGTATGGACGTCTGGGGCC., 
TACTACTACGGTATGGACGTCTGGGGCC,, 
TACTACTACGGTATGGACGTCTGGGGCC.. 
ACGGTATGGACGTCTGGGGCC.. 
TACTACTACGGTATGGACGTCTGGGGCC,. 
ACGGTATGGACGTCTGGGGCC.. 
TACTACTACTACGGTATGGACGTCTGGGGCC.. 
TACTACTACGGTATGGACGTCTGGGGCC.. 
TACGGTATGGACGTCTGGGGCC. 
ATTACTACTACTACTACGGTATGGACGTCTCGCGCC.. 
CTAACTGGGGA  GCCTGCTTTTCGG] 
LTCCCCATACTC~  ~TTACTACTACTACTACGGTATGGACGTCTGGGGCC., 
CTAA  ATTTCGAGTCCCATGTCTCG~ 
LGGTTCGGGGGAGCGGGCGAA  TACGGTATGGACGTCTGGGGCC..~ 
vector e-GG__6A  TCC  GT  CTACTACTACGGTATGGACGTCTGGGGCC.., 
Bam  HI  J 
B 
DHO52 
Clone  1 
JH4 
"CTAACZGGG1A" 
C~C~GCG~CCAGGCAACCCTG.  .  . 
qACTACTTTGAC~CTGgGqCCAGGGAACCCTG.. 
Figure  3.  Nudeotide  sequences  of  D.q52-J. rearrangements  from 
normal  bone marrow  of two adult donors.  The DNA was  cut before 
amplification with restriction enzyme EcoN I. (.4) Normal sequences:  Du- 
bious nudeotides which could represent D.Qs2 as well as JH elements were 
scored as D~sz segment.  P nucleotides are underlined. Sequence compar- 
ison was done according to a published report (asterisk, reference 43). Se- 
quence variations of J. elements as reported by Yamada et al. (44) are in- 
cluded for comparison.  RSS are drawn as triangles. (B) An overlapping 
sequence of D,~s2 and .[.4, which could be due to homologous recombi- 
nation in clone 1 (20)  is boxed. 
used the last two Y  nucleotides before the Y  RSS of DaQS2 
as junctional nudeotide.  The junctional nucleotides at  the 
5' site of J,6 were spread more evenly, reaching from the first 
to  the seventeenth  base with a peak  at base nine. 
Possible pallindromic sequences (P elements) (18) were de- 
tected in 47% of the clones which had not deleted  nucleo- 
tides  at the ends of the coding elements (done 14,  18,  19, 
27, 28, 30). We obtained one clone (clone 30, Fig. 3 A) which 
bad vector  sequences  directly  followed by P/N nudeotides 
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Figure 4.  Anal)sis of D.Qs2-J. rearrangements in PBMC  DNA from 
B + SCID patients. Oligonucleotides  2 and 6 were used for amplification, 
probe a for hybridization, Hind III digested ;%  DNA served as size marker. 
As template the following (DNA) samples (cut with EcoN I) were in- 
cluded: Lane I, water, treated identically like the samples; lane 2, PBMC 
(normal); lane 3, patient 1 (D. B.); hne 4, patient 2 (D. D.); lane 5, pa- 
tient 3  (K. K.);  lane 6, patient 4  (F. P.); lane  7,  patient  5 (M.  Z.). 
and the J,6  element.  The presence  of the vector  sequence 
most likely was due to a 3  nucleotide P dement insertion 
at the 3' site of D,Q52 which creates a BamH I site and jux- 
taposes  P/N  elements to  vector  sequences. 
Of six clones without N nudeotides (Fig. 3 A), three con- 
tained overlapping  sequences  of D.Qs2 and JR4 or J.6  (done 
1, 8, 9). The overlap of one done (done 1) (Pig. 3 B) encom- 
passed seven nudeotides. Clone 8 and 9 (Fig. 3 A) overlapped 
by one base. One possible mechanistic explanation for such 
an overlap (as seen in done 1) could be a homologous recom- 
bination event,  as previously suggested  (20). 
DxQs2-J~, Recombinations In  Severe Combined Immuno- 
deficiency  (SCID) Patients.  The amplification of PBMC DNA 
(digested  with EcoN I) from B + SCID patients and the hy- 
bridization to probe a after blotting revealed that all five B § 
SCID patients show a D.Qs2-J, recombination pattern iden- 
tical  to  normal controls  (Fig.  4). 
The amplification ofEcoN I digested bone marrow DNA 
of six B-  SCID patients  showed that all of them exhibit a 
grossly irregular recombination  pattern following hybridiza- 
tion to probe a (Fig.  5 A) or probe b (Fig.  5 B).  Common 
to all six samples is the disturbance of the normal recombi- Figure  5.  Analysis of D.Qs2-J. 
associated rearrangements  in bone 
marrow DNA from B- SCID pa- 
tients.  Oligonucleoddes  2  and 6 
were used for amplification. Probe 
a (A) and probe b (B) were hybrid- 
ized to the identical filter. Mol wt 
marker, Hind III digested X DNA. 
The following  samples pretreated 
with EeoN I were included in the 
analyses: Lane 1,  water;  lane  2, 
healthy control 1; lane 3, healthy 
control 2; lane 4, patient 6 (V. M.); 
lane 5, patient 7 (T. C.); lane 6, pa- 
tient  8  (P.  P.),  lane  7,  patient  9 
(J. B.), lane 8, patient 10 (J. J.); lane 
9, patient  11 (S. K.). 
nation "ladder". However, the amplification products repre- 
sent a heterogenous pattern: one patient (patient 9, Table 1) 
did not show any rearranged fragment (Fig.  5, lane 7), all 
other patients revealed the absence of some bands (Fig.  5, 
lane 4-9)  and, in addition, several patients (patient 6,  10, 
and 11) showed amplification products which were of excep- 
tional size (Fig.  5, lane 4, 8, and 9), i.e., not representing 
regular DaQs2"J. recombinations. 
The latter interpretation was supported by the hybridiza- 
tion of the filter used in Fig. 5 A  to probe b (Fig. 5 B). Pa- 
tients 6 and 10, who had irregularly hybridizing bands with 
probe a, lost some of those signals after hybridization to probe 
b. Thus the upstream regions of these putative D,Qsz-J. rear- 
rangements have obviously lost hybridizable sequences which 
span from oligonucleotide 2 to sequences between J.2 and 
J.3.  Amplification of PBMC  DNA  of patient  6  and  10 
showed similar  patterns of D,62-J. recombinations as ob- 
served in bone marrow DNA (data not shown). Genotypic 
analysis of the immunoglobulin gene status  was done on 
PBMC or bone marrow DNA after digestion with Bgl II 
or Hind III and Southern blot analyses using probe a (Fig. 
1). The probe hybridized in all patients to 3.9 kb Bgl II and 
to 9.5 kb Hind III germline fragments, indicating that no 
gross DNA abnormalities were present within the analyzed 
Ig gene loci (data not shown). 
Sequence Analysis of B- Severe Combined Immunodeficiency 
(SCID) Patients.  Nucleotide sequences  derived from am- 
plification products of bone marrow DNA (EcoN I or Bgl 
II digests)  of two B-  SCID patients were in marked con- 
trast to the results obtained in healthy donors. We detected 
only two clones ($6E2 and $10B3) containing P nucleotide 
insertions, which resembled regular JH, rearrangements (Fig. 
6 A). However, the other clones showed deletions of different 
sizes (Fig. 6 B). In all clones the 5' breakpoint occurred be- 
tween the upstream amplification primer and D.qs2. The 3' 
breakpoint occurred always within a J, element; clone $10B2 
exhibits a deletion of 51 nucleotides of J.6  sequences, thus 
by far exceeding the normal range of J.6 nucleotide loss in 
normal DJ junctions. Three of the deletion clones contained 
N  sequences, supporting the view that this step in V(D)J 
recombinations is not mutated in B-  SCID patients. 
Hybridization of a clonospecific sequence derived from one 
deletion clone (clone S10B1) (Fig. 6 B) to the Southern blot 
analysis of amplification products (Fig. 7 C) additionally sup- 
ported  the  interpretation that  aberrant  fragments  in  the 
Southern  blot  analysis actually  represent  irregular  rear- 
rangement  s. 
Abnormal Rearrangements In Normal Bone Marrow Donors. 
Since we detected abnormal recombinations in B-  SCID pa- 
tients,  we  asked  if recombination failures  are  unique  to 
B-  SCID patients or if these irregular recombinations can 
also be detected in normal individuals.  To enrich for the de- 
tection of deletional events, we digested the DNA of two 
normal bone marrow donors and three B-  SCID patients 
with Bgl II prior to the analyses; Bgl II cuts at position 331, 
thus  between  the  5'  amplification  ogligonucleotide and 
D,Qs2. Therefore only those events that have deleted posi- 
tion 331 can serve as intact template during the amplification 
procedure besides a small amount of uncut regular D,Qs2-J, 
rearrangement events. Fig. 7 A shows the result of a Southern 
blot analysis of amplification products after hybridization to 
probe a.  In fact,  healthy persons (Fig.  7,  lane  I  and 2)  as 
1044  JH Rearrangement  in B-  Severe Combined Immunodeficiency  (SCID)  Patients A 
~092  P  N  JUt 
4CTAACTGGGGA~  "ACTACTTTGACTACTGGGG.,, 
$6E2  vector ~- GGA  TCC  CTTTGACTACTGGGG... 
SIOB3  vector *-  GG__~A  TCC  TAACGGCC  ACTTTGACTACTGGGG.. 
t  BamHl  J 
B 
310  621 
5'of  DHO52  .  .GRTGAGRGG2~.GCGTGACAGAC  .....  //  ......  ,DMo52  b 
S6E]  .. GATGAGAGGT  TTTCTGTCACGCCACCTCCCAGGTAGACTTAC  TACTACTACTACTACATGG.  . 
JM6  ,ATTACTACT~CTACTACATGG.  . 
2949 
212  621 
5*of DHO52  ..CAGCGAGGAGCCTGCGCGCCCTGCC  ....  //...4DHo52b 
S6BI  .. CAGCGAGGAGCC  CTACTCCTACTACCAC TACTACTACTACTACATGGACG.  . 
JR6  ,ATTACTAETACTACTACATGGACG.  . 
2949 
105  621 
5'0f DHQ52  ..QRCGACGGTGAACAGGTGGAACCAA  ....  //...,DHQ52~ 
SIOBI  ￿9  GACGACGGTGAAC  CC  CTTTGACTACTGGGGCCAGGG.  . . 
Js4  dACTACTTTGACTACTGGGGCCAGGG~  ￿9 
1916 
105  62] 
5  'of DHOS2  ..  GACGACGGTGAACAGGTGGAACCAA...//..  4DHQ52  b 
$1082  .. GACGACGGTGAACGTCTCCTCAGGTARGAATGGCCA  . . . 
JH6  "JH6  ￿9 "//"  .GACCACGCTCACCGTCTCCTCAG~TAAGAATGGCCA.  , . 
2947  2998 
Figure 6.  Nucleotide sequences of D.qsz-J. associated rearrangements 
from bone marrow of B-  SCID patients. The letter B or E (B  =  Bgl 
II, E =  EcoN I) in the clone identification number represents the restric- 
tion enzyme used prior to the amplification. Sequence comparison was 
done according to published reports  (43, 44). P nuclemides are under- 
lined, R.SS are drawn as triangles. The sequence of the clonospecific oligo- 
nucleotide (betu, ee. arrows) used for hybridization analysis (Fig. 7 C) was 
derived from clone S10BL 
well as SCID patients (Fig. 5, lane 3-5) exhibit irregularly 
sized fragments. Upon rehybridization of the filter to probe 
b  (Fig.  7 B), most of the irregular bands either lose their 
intensity or are no longer visible, indicating that deletions 
between oligonudeotide 2 and J,2-J.3 must have occurred. 
After cloning Bgl II digested amplified DNA of a healthy 
person, one clone (done 31) (Fig. 8) had an irregular recom- 
bination pattern, since a deletion of 1584 bp (from base pair 
273 to 2857) was detected. The point of recombination did 
not include any coding elements nor were any cryptic RSS 
visible in the vicinity of the breakpoints. Thus no principle 
difference  between  normal  bone  marrow  donors  and 
B- SCID patients is observed in this analysis. We conclude 
that irregular rearrangements are present, albeit rare in normal 
individuals. 
Discussion 
We have studied the pattern of Ig gene rearrangements 
in five B + and six B- human SCID patients by a PCR assay 
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amplifying the D,Qs2-J, region. Either by Southern blot or 
by sequence analyses the amplification products were charac- 
terized in more detail. At the Southern blot level B + SCID 
patients showed a normal D,Qs2-J. recombination pattern, 
indicating a regular function of the "recombinase" machinery 
in this disease subentity. 
In contrast, all six B-  SCID patients showed a grossly 
disturbed recombination pattern in the Southern blot anal- 
),sis, with the lack of or with faulty D,Qs2-J, rearrangements. 
Sequence analyses of the amplification products of B- SCID 
patients showed that a high percentage of the rearrangements 
included deletions which surpass the boundaries of coding 
elements. This finding resembles the molecular defect in the 
SCID mouse (25-29). Since the used PCR approach allowed 
the detection of either normal rearrangements or ofjoinings 
with relatively small deletions on both sides flanking either 
D.Qs2 or the J, duster, we expected to amplify only a minor 
proportion of recombinations and especially deletion events. 
Given the recombination defect in B-  SCID patients, this 
might explain why each patient exhibits a characteristic lack 
of usage of particular L. Additionally, the clonal expansion 
(possibly  driven by antigenic stimuli) of a few cells bear- 
ing  a  normal D.Qs2-J, rearrangement  might  explain  the 
oligoclonal pattern of normal recombinations detected in 
B- SCID patients. Whether these bands are generated due 
to the leakiness of the recombination machinery remains to 
be established. 
The enzymatic pathway of Ig gene recombination has been 
divided into specific steps which are either mediated by the 
RSS or by nonspecific DNA processing enzymes (46). After 
RSS are identified by the recombination protein(s) and (prob- 
ably) brought into physical proximity, cutting occurs at the 
P..SS borders. Upon cleavage, the recombination machinery 
might continue to hold the coding and signal ends in close 
proximity to one another. The cut intermediates have to be 
quite stable since they must be long-lived enough to allow 
polymerases and exonucleases to modify their termini. There- 
after, the ligation of the open ends will restore the integra- 
tion of the DNA strand. The two normal clones sequenced 
in our B- SCID patients and the presence of N nudeotides 
in the deletion clones indicate that the B-  SCID recombi- 
nation machinery is competent for the recognition of R.SS, 
cutting at the RSS sites and the addition of P and N nudeo- 
tides. The defect associated with B-  SCID may rather rep- 
resent a step marking the end of the trimming process of 
the coding elements. Along this line, one of the two alleles 
of a transformed cell line derived from a B cell negative (0% 
B cells, 7% T cells) SCID patient showed a rearrangement 
of the DLgl element to a region 60 nudeotides downstream 
from J,4, while the second allele represented a normal D,~l-~s 
recombination (14). 
Our data also provide evidence for the current view that 
irregular Ig recombinations are not exclusively observed in 
B- SCID patients. The existence of one sequenced deletion 
clone and several irregular fragments in the Southern blot 
analysis of healthy individuals points to this fact. Occasion- 
ally lymphocyte precursors escape the otherwise tightly con- 
trolled recombination process of normal lymphopoiesis. Like- Figure 7.  Analysis of D.QsrJ. associated rearrangements in bone marrow DNA obtained from healthy probands and B- SCID patients. Oligonude- 
otides 2 and 6 were used for amplification;  probe a (A), probe b (B) and the donospecific oligonucleotide 5' GGT GAA CCC CTT TGA CTA CTG 
GC~ 3' (C) were hybridized to the identical filter. The separation was done on a 1.2%  agarose  gel.  Markers  as in Fig. 2.  The following samples 
pretreated with Bgl II were included in the analyses: Lane 1, healthy individual 1; lane 2, healthy individual 2; lane 3, patient 6 (V. M.); lane 4, patient 
7 (T. C.); lane 5, patient 10 (J. J.).  Arrowheads in A  indicate bands which show a reduced  intensity after hybridization to probe b  (B). 
wise, sequencing of several B cell derived clones in the Balb/c 
mouse (47) has identified only one clone (clone 266 in [47]) 
where sequences 5' of D.Qs2 are rearranged to a region which 
is downstream of J.4. 
One of the critical  points concerning our PCR assay is 
the presence of maternal T  cells in B-  SCID patients since 
it has been realized  that T  cells can undergo DaJ. but no 
complete V.D,J, rearrangement (48). These maternal T cells 
could account for the presence of the normal rearrangements 
in our B- SCID panel. Two observations argue against this 
implication:  (a)  B-  SCID  patient  7  (T.C.)  who  had  no 
273  621 
5' of  DHQ52  .  .  . CCGCCACCCGGGCCTCTCTGCTGCTGGGAAAACA...//..  "DHQ52 ￿9 
Clone  31  ...CCGCCACCCGGGCCTCTCTGCTGGACAGTCAGCTTCCAT  ......... 
5 '  of  JH6  .  ￿9  .  CGACAGGGCCACGGACAGTCAGCTTCCAT.  ￿9149  "JH6 
2857  2947 
Figure 8.  Sequence of a deletional clone obtained after amplification 
of Bgl II digested DNA of a healthy individnal. Sequence comparison was 
done according to published reports (43, 44). Arrowheads represent KSS. 
maternal T cells on the basis of fluorescence analysis and in 
vitro culture of PBMC (Table 1) showed a similar recombi- 
nation pattern as other B-  SCID patients; (b) amplification 
of 99% pure (by cytofluorometry) peripheral T cells of two 
normal donors yielded the normal recombination ladder as 
observed with PBMC or bone marrow of healthy persons 
(K.  Schwarz,  unpublished data).  In vitro culture of PBMC 
or of lymphocytes from different organ biopsies of patient 
6 (V. M.) and patient 10 (J. J.) yielded cell lines with >90% 
CD3 positive cells which were of maternal origin only. Yet, 
preliminary PCK analyses of those CD3 positive cell lines 
revealed only the germline band (K.  Schwarz,  unpublished 
data). Thus those maternal cells either have no D.qs2"J,~ rear- 
rangement at all or they use other D, sequences outside of 
the range of our PCK primers. 
Whether pre T cells of the B-  SCID patients recombine 
TCK genes with faults remains to be established.  Patients 
lacking maternal T cells might allow to approach this problem. 
The identification of B- human SCID patients who may 
be characterized  by a defect within the recombination ma- 
chinery analogous to SCID mice opens new avenues as to 
the differential diagnosis of SCID patients and marks a step 
towards the molecular definition of these heterogeneous en- 
tities. 
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